secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001636422-23-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q4 revenue $69.2M (+7% YoY); Adjusted EBITDA loss narrows; board adds Matthew Kolb
--------------------------------------------------------------------------------

- Q4 total revenue $69.2M (+7% YoY); full-year revenue $276.2M (+14% YoY).
- GAAP net loss Q4 $35.8M vs $49.0M loss a year ago; full-year net loss $137.4M vs $153.2M.
- Adjusted EBITDA Q4 -$0.6M (improved 90% from -$6.3M); full-year -$2.5M (improved 78% from -$11.2M).
- Matthew Kolb (EVP/COO Carle Health) to join board effective July 1, 2023; Carle Health made open-market stock purchase.
- CEO Dan Burton purchased shares on open market, estimates he is among top 20 shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/0001636422-23-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/hcat-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001636422-23-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer